Warner Chilcott Announces FDA Approval of New Ulcerative Colitis Product Delzicol

DUBLIN, Ireland, Feb. 5, 2013 -- Warner Chilcott plc today announced that the United States Food and Drug Administration (FDA) has approved its new 400 mg mesalamine product indicated for the treatment of ulcerative colitis. The product will be...

Source: Drugs.com - New Drug Approvals - February 6, 2013 Category: Drugs & Pharmacology Source Type: news